Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Faron Pharmaceuticals
immunotherapy, MDS
Sahand Hormoz
MPN
Ari Melnick
epigenetics and lymphoma
Yoke Seng Lee
AML
Steven Treon
Lymphomas and Waldenstrom's
Taishi Yonezawa
AML
Venkata Lokesh Battula
immunotherapy and AML
Bingyi Chen
AML immunotherapy
Sarah Tasian
pediatric leukemias
Inhye Ahn
CLL
Stacie Dusetzina
Equity in Access
Anushree Vichare
Equity in Access
Peter Croucher
Multiple Myeloma
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Markus Muschen
leukemia and lymphoma biology
Daniel Pollyea
AML
James Rubenstein
Lymphoma of the Central Nervous System
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Ann-Kathrin Eisfeld
Racial diversity in AML
Jianguo Tao
Mantle Cell Lymphoma
Christopher Porter
Leukemia, lymphoma
Matteo Bellone
Smoldering multiple myeloma
Jeffrey Magee
pediatric AML
ImCheck Therapeutics
immunotherapy, AML
Leandro Cerchietti
DLBCL
Paolo Strati
Non-Hodgkin Lymphoma
Reina Takeda
AML
Bruno Paiva
smoldering myeloma
Jake Shortt
precision therapy for aggressive lymphomas
Shannon Maude
Immunotherapy for ALL
Michael Keller
COVID-19, immunotherapy
Michael Green
lymphoma biology
Huda Salman
CMML
Kimberly Stegmaier
childhood blood cancers
Coleman Lindsley
AML/MDS
Rgenta Therapeutics
RNA-targeting, blood cancer
Xu Ji
Equity in Access
William Matsui
Myeloma
Liran Shlush
pre-leukemia
Enrico Tiacci
Hairy cell leukemia
Andrew Lane
BPDCN
Steven Park
follicular lymphoma
Logan Spector
childhood leukemia epidimiology
Rachel Mersfelder
AMKL
Christopher Flowers
clinical trial access
Robert Orlowski
(Smoldering) Multiple Myeloma
Jeetayu Biswas
splicing in myeloid diseases
Tanya Siddiqi
clinical trial access
Kirk Schultz
pediatric transplantation
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Wendy Béguelin
follicular lymphoma
Mark Hamilton
DLBCL and CAR-T
Martin Dreyling
Mantle Cell Lymphoma
Rong Lu
preleukemia, leukemia
Sriram Sundaravel
AML stem cells
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Sisi Chen
leukemia
Lakshmi Nayak
brain tumors in lymphoma
Mark Dawson
B-ALL and CAR-T resistance
Jaehyuk Choi
T-cell lymphoma
Simona Colla
Myeloma biology
Suman Paul
T cell cancers and immunotherapy
Peter Klein
MDS
Grzegorz Nowakowski
Clinical trial access
Michael Savona
MDS and leukemia
Sheng Li
Aging and AML
Frederick Locke
lymphoma and immunotherapy
Daisuke Nakada
preleukemia, leukemia
Fahmin Basher
transplant and GvHD
Michael Wang
Mantle Cell Lymphoma
Jonas Jutzi
myeloproliferative neoplasms
Omar Abdel-Wahab
Hairy cell leukemia
Stephen Oh
myeloproliferative neoplasms
Neha Mehta-Shah
T-cell lymphoma
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Ronald Levy
immunotherapies, COVID-19
Meng Li
Equity in Access
Daniel Lucas
bone marrow and leukemia biology
Roland Walter
Antibody-based AML therapies
Sam Butterworth
CMML
Lev Kats
myeloma and epigenetics
Christian Marinaccio
MLL leukemias
Dimericon Therapeutics
dimericons, blood cancer
Daniel Starczynowski
MDS and AML
Amin Sobh
Myeloma biology
Bailee Kain
AML and African ancestry
Anouchka Laurent
T-cell lymphoma
Nicolas Nassar
pediatric leukemia
Takeshi Sugio
T-cell lymphoma
Alex Kentsis
pediatric leukemias
Courtney Jones
AML metabolism
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Julia Maxson
AML
Adi Nagler
Bronchiolitis obliterans after transplant
Richard Lock
T-ALL
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Paolo Caimi
CAR-T clinical trial for CLL
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Ryan Wilcox
T-cell lymphoma
H. Irene Su
Equity in Access
Michael Kharas
leukemia
Liling Wan
AML
Soheil Meshinchi
pediatric AML
Nataly Cruz-Rodriguez
T-ALL and metabolism
Fenghuang Zhan
Myeloma and bone disease
Nicoletta Cieri
AML and transplantation
Ravi Bhatia
transplantation
Hao Jiang
DNA biology and leukemia
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Siegfried Janz
Myeloma immunotherapy
Suzanne Lentzsch
Myeloma
Brian Walker
smoldering myeloma, MGUS
Wendy Stock
T-cell ALL
Jessica Stewart
Epstein-barr virus and lymphomas
Jeremy Baeten
AML
Keisuke Ito
blood cancer stem cells and MDS metabolism
Yubin Zhou
peripheral T cell lymphoma
Lucy Godley
preleukemia
Urvi Shah
Diet and myeloma
Kathleen Sakamoto
pediatric AML
Tyler Parsons
MPN and AML
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Cailin Collins
Leukemia and pre-leukemia
Jianhua Yu
myeloma immunotherapy
Kasey Leger
pediatric blood cancers
Adam Olszewski
Follicular and marginal zone lymphoma
Jing Fu
myeloma
Saar Gill
AML immunotherapy
Amit Verma
AML/MDS
Gaurav Goyal
Erdheim-Chester Disease
Marc Seifert
Hairy cell leukemia
Elliot Stieglitz
CMML
Justine Kahn
pediatric leukemia and lymphoma
Solu Therapeutics
immunotherapy, CMML
John Leonard
lymphoma research
Riccardo Dalla-Favera
lymphoma (DLBCL)
Jonathan Licht
DNA biology, myeloma
Armin Rashidi
gut bacteria and transplant success
Courtney DiNardo
clinical trials, AML
Arash Alizadeh
blood cancer biology and diagnosis
Alieen Rowan
Adult T cell leukemia/lymphoma
Jennifer Woyach
CLL trials
BioInvent International
immunotherapy, indolent NHL, CTCL
George Daley
"off-the-shelf" CAR-T and CAR-NK
Jonathon Cohen
lymphoma clinical trial access in Georgia
Brian Dalton
DNA mutations and myeloid cancers
Carl June
CAR T immunotherapy
Alfred Garfall
myeloma immunotherapy
Pietro Genovese
transplant and AML
Gianpietro Dotti
CAR T and AML
Piers Patten
COVID-19
Nizar Bahlis
Myeloma immunotherapy
Alexey Danilov
lymphoma
Gareth Morgan
smoldering myeloma, MGUS
Roberta Zappasodi
lymphoma, immunotherapy
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Mark Murakami
follicular lymphoma
Affimed
immunotherapy, HL, PTCL
Jennifer Trowbridge
aging and leukemia
Thomas LeBlanc
palliative care
Jalpa Doshi
Equity in Access
Michaela Reagan
Multiple Myeloma
Noemí Puig Morón
Myeloma
Mendel Goldfinger
MDS/AML trials for the elderly
John DiPersio
trispecific antibody for AML and MDS
Lindsey Montefiori
pediatric leukemia
Yibin Yang
Lymphoma
Daniel Herranz
T-ALL
Jean Koff
Disparities in DLBCL
Christine Zhang
AML
Carl Allen
pediatric blood cancers
Qingyu Luo
BPDCN
Ruben Carrasco
Myeloma
Ravindra Majeti
preleukemia, AML
Eric Pietras
AML
Rajni Kumari
AML
Raymond Mailhot
Equity in Access
Stephen Gottschalk
pediatric leukemia and CAR-T
Timothy Graubert
AML and MDS biology
Nirav Shah
CAR-T for lymphoma
Jolanta Grembecka
leukemia therapeutics
Maximilian Stahl
AML immunotherapy
Caron Jacobson
lymphoma and immunotherapy
Qing Yi
Novel CAR-T
Megan McNerney
AML/MDS
Luca Busino
DLBCL
Christian Steidl
B-cell lymphomas
Eric Padron
CMML
Philippe Armand
follicular lymphoma
Jayna Mistry
aging and leukemias
F. Lennie Wong
Equity in Access
Matthew Frank
Lymphoma CART therapy
Kerry Rogers
CLL
Craig Jordan
AML
Ricky Johnstone
lymphoma and myeloma
Joachim Yahalom
Lymphoma
Carma Bylund
Equity in Access
Shazia Nakhoda
Equity in Access
Caner Saygin
T-ALL
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Britta Will
Leukemia and pre-leukemia
Eirini Papapetrou
blood cancer stem cells
Caroline Arber
myeloma CAR-T
Jaroslaw Maciejewski
bone marrow failure
Jing Yang
Myeloma
Hong Wen
AML
Srividya Swaminathan
pediatric, immunotherapy
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Catriona Jamieson
cancer stem cell biology
Yan Liu
MDS
Marina Konopleva
MDS/AML metabolism
Paul Beavis
immunotherapy in myeloma
Yiman Liu
Epigenetics and leukemia
Alison Moskowitz
lymphoma therapeutics
Tak Mak
Immunotherapy
Susan Schwab
cancer immunology
Randall Davis
CLL
Oreofe Odejide
Equity in Access
Enterome
vaccine, FL, MZL
Marco Ruella
Immunotherapy for T-cell lymphoma
Tomasz Skorski
myeloproliferative neoplasms, AML
Christopher Booth
BPDCN
Daniel Thomas
Myelofibrosis
Robert Soiffer
transplantation
Jun Qi
Myeloma
Kura Oncology
MLL leukemia, AML
Koichi Takahashi
AML/MDS
Lawrence Boise
CART and myeloma
Helen Parsons
Equity in Access
Siddhartha Jaiswal
preleukemia
Sergei Doulatov
Leukemias
Dan Landau
cancer evolution biology
Ana Vujovic
AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Adam de Smith
pediatric ALL and Down Syndrome
Stephen Nimer
myeloid cancer biology
Nitin Jain
CLL
Bing Carter
p53 mutant AML
Alec Zhang
myeloma, immunotherapy
Eugenio Morelli
Myeloma
Constellation Pharmaceuticals
myeloproliferative neoplasms
Catherine Smith
leukemia
Margaret Shipp
lymphoma biology
Areej El-Jawahri
transplant survivorship
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Grant Challen
preleukemia, leukemia
Tycel Phillips
Mantle Cell Lymphoma
Rizwan Romee
Immunotherapy
Steven Horwitz
T-cell lymphomas
Anthony Letai
improving CAR-T
Manyi Wei
acute megakaryoblastic leukemia
Lori Muffly
Equity in Access
John Crispino
myelofibrosis, pediatric leukemia and Downs
Pooja Khandelwal
bone marrow transplantation
Dane Vassiliadis
blood cancer biology
Jenny Wang
AML
Catherine Bollard
pediatric blood cancers and immunotherapy
Julia Paczkowska
immunobiology of Hodgkin's disease
Mala Shanmugam
myeloma
Thomas Kipps
Hairy Cell Leukemia
Teresa Palomero
Peripheral T-cell Lymphoma
Thomas Koehnke
leukemia
Sigurður Kristinsson
Smoldering myeloma
Nicola Vannini
Aging and CAR-T success
Catherine Diefenbach
DLBCL immunology
Frederike Kramer
MPNs
Sham Mailankody
Myeloma immunotherapy clinical trials
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Trent Hall
MDS
Madhav Dhodapkar
multiple myeloma immunotherapy
George Vassiliou
Leukemia Prevention